• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.

作者信息

Dekitsch Christine, Schein Robert, Markopulos Effi, Kuen Beatrix, Graninger Wolfgang, Georgopoulos Apostolos

机构信息

Institut fÜr Mikrobiologie und Genetik, Biozentrum der Universität Wien, Vienna, Austria.

出版信息

J Med Microbiol. 1999 Jan;48(1):73-77. doi: 10.1099/00222615-48-1-73.

DOI:10.1099/00222615-48-1-73
PMID:9920128
Abstract

The gyrA subgenes of a quinolone-resistant Enterobacter cloacae clinical isolate (ofloxacin MIC, 16 mg/L) and of a control, E. cloacae NCTC 10005 (ofloxacin MIC, 0.03 mg/L), were amplified by polymerase chain reaction (PCR) and sequenced. The resistant isolate had mutations at the codons for amino acids 83, 89 and 90. The first of these mutations led to replacement of serine-83 by tyrosine, whereas the other mutations were silent. Digestion of PCR-amplified DNA fragments with the restriction enzyme HinfI detected mutations at the same site in gyrA in six further quinolone resistant E. cloacae isolates.

摘要

相似文献

1
Analysis of mutations to gyrA in quinolone-resistant clinical isolates of Enterobacter cloacae.
J Med Microbiol. 1999 Jan;48(1):73-77. doi: 10.1099/00222615-48-1-73.
2
Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.阴沟肠杆菌喹诺酮耐药临床分离株中gyrA和parC基因突变的检测
J Antimicrob Chemother. 1997 Oct;40(4):543-9. doi: 10.1093/jac/40.4.543.
3
Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.弗氏柠檬酸杆菌临床分离株喹诺酮耐药机制分析
J Antimicrob Chemother. 1999 Dec;44(6):743-8. doi: 10.1093/jac/44.6.743.
4
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.用于检测大肠杆菌中gyrA基因突变的快速检测方法的开发以及从复杂性尿路感染患者分离的临床菌株中gyrA基因突变发生率的测定。
J Clin Microbiol. 1997 Sep;35(9):2315-9. doi: 10.1128/jcm.35.9.2315-2319.1997.
5
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.环丙沙星、克林沙星、加替沙星、左氧氟沙星、莫西沙星和曲伐沙星对肺炎克雷伯菌、产酸克雷伯菌、阴沟肠杆菌和气生性肠杆菌临床分离株的体外比较活性,这些分离株的GyrA和ParC蛋白发生了改变。
Antimicrob Agents Chemother. 1999 Aug;43(8):2051-5. doi: 10.1128/AAC.43.8.2051.
6
Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin.肺炎链球菌临床分离株parC和gyrA基因突变与对环丙沙星和格帕沙星耐药性的关系。
J Med Microbiol. 1999 Dec;48(12):1103-1106. doi: 10.1099/00222615-48-12-1103.
7
Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.环丙沙星与氟喹诺酮类药物。作用机制与耐药性的新概念
Am J Med. 1989 Nov 30;87(5A):2S-8S. doi: 10.1016/0002-9343(89)90010-7.
8
Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China.来自日本和中国的喹诺酮耐药及耐甲氧西林金黄色葡萄球菌分离株中4-喹诺酮耐药机制
J Med Microbiol. 1995 Mar;42(3):214-9. doi: 10.1099/00222615-42-3-214.
9
Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.印度多重耐药伤寒沙门氏菌临床分离株中导致对4-喹诺酮类药物敏感性降低的突变
J Antimicrob Chemother. 1996 May;37(5):891-900. doi: 10.1093/jac/37.5.891.
10
Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.阴沟肠杆菌临床分离株及其他携带qnrA基因的肠杆菌科细菌中的II型拓扑异构酶突变
Int J Antimicrob Agents. 2007 Apr;29(4):402-9. doi: 10.1016/j.ijantimicag.2006.11.008. Epub 2007 Jan 23.

引用本文的文献

1
Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.嗜麦芽窄食单胞菌临床分离株中拓扑异构酶II和IV喹诺酮耐药决定区与不同水平的喹诺酮敏感性
Antimicrob Agents Chemother. 2002 Mar;46(3):665-71. doi: 10.1128/AAC.46.3.665-671.2002.